Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
This study has been completed.
Sponsor:
Insys Therapeutics Inc
Collaborator:
Georgetown University
Information provided by:
Insys Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT00024661
First received: September 24, 2001
Last updated: April 12, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | October 2004 |
| Estimated Primary Completion Date: | No date given |